© 1987 The Gerontological Society of America
Age and Alpha-2 Adrenergic Regulation of Plasma Norepinephrine Kinetics in Humans
1 Geriatric Research, Education, and Clinical Center, Seattle Veterans Administration Medical Center
2 Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine
3 Department of Medicine, University of Washington School of Medicine
| Abstract |
|---|
To investigate whether the age-related elevation of plasma norepinephrine (NE) is due to impaired alpha-2 adrenergic inhibition of sympathetic nervous system (SNS) outflow, arterialized plasma NE kinetics were measured before and 120 to 140 min after 1.5 and 5.0 µ.gmlkg oral clonidine in 6 old (57 to 78 years) and 8 young (25 to 39 years) normotensive male volunteers. Baseline plasma NE levels were higher in old compared with young men (M ± SEM, 355 ± 58 vs. 197 ± 22 pglml, p < .02). Clonidine produced significant (p < .05) dose-related reductions in plasma NE, NE appearance rate, NE clearance, and mean arterial blood pressure (MAP) in both groups. There was no difference between old and young men in response to low dose clonidine. Following the higher dose, both groups had similar suppression of plasma NE (– 51 ± 7% vs. – 58 ± 2%, p > .05) and NE appearance (– 60 ± 6% vs. – 62 ± 2%, p > .05), but older men had a greater fall in NE clearance (– 20 ± 2% vs. – 10 ± 1%, p < .003) and MAP (– 28 ± 3% vs. – 10 ± 4%, p < .006). These findings suggest that sensitivity to alpha-2 receptor-mediated suppression of plasma NE and NE appearance is not diminished in elderly men.
Received for publication May 30, 1986. Accepted for publication October 30, 1986.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. S. Thompson, L. A. Holowatz, and W. L. Kenney Cutaneous vasoconstrictor responses to norepinephrine are attenuated in older humans Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1108 - R1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R Seals and M. D Esler Human ageing and the sympathoadrenal system J. Physiol., November 1, 2000; 528(3): 407 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Petrie, E. R. Peskind, D. J. Dobie, R. C. Veith, and M. A. Raskind Increased Plasma Norepinephrine Response to Yohimbine in Elderly Men J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2000; 55(3): 155M - 159. [Abstract] [Full Text] |
||||
![]() |
R. Willenbrock, S. Philipp, V. Mitrovic, and R. Dietz Neurohumoral blockade in CHF management Journal of Renin-Angiotensin-Aldosterone System, March 1, 2000; 1(1_suppl): 24 - 30. [Abstract] [PDF] |
||||
![]() |
E. R. Peskind, D. Wingerson, S. Murray, M. Pascualy, D. J. Dobie, P. Le Corre, R. Le Verge, R. C. Veith, and M. A. Raskind Effects of Alzheimer's Disease and Normal Aging on Cerebrospinal Fluid Norepinephrine Responses to Yohimbine and Clonidine Arch Gen Psychiatry, September 1, 1995; 52(9): 774 - 782. [Abstract] [PDF] |
||||
![]() |
R. C. Veith, N. Lewis, O. A. Linares, R. F. Barnes, M. A. Raskind, E. C. Villacres, M. M. Murburg, E. A. Ashleigh, S. Castillo, E. R. Peskind, et al. Sympathetic Nervous System Activity in Major Depression: Basal and Desipramine-Induced Alterations in Plasma Norepinephrine Kinetics Arch Gen Psychiatry, May 1, 1994; 51(5): 411 - 422. [Abstract] [PDF] |
||||




